Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Repeated Doses of TKT001-S in Healthy Japanese Adult Males
jRCT2071240129Phase 1Completed
- Sponsor
- SEREN Pharmaceuticals
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing TKT001-S repeated doses with Placebo repeated doses (2 arms). Primary endpoints: Pharmacokinetics of TKT001-S, Safety and 1 more. Started May 2025; status: completed.
02
Drugs
TKT001-S
Beyond the preview
Go deeper on jRCT2071240129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240129.